ArticleJournal of natural medicines2026
Ginsenoside Rd promotes the expression of acetylated α-tubulin and FOXJ1 in human bronchial epithelial cells.
Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucociliary clearance is an airway defense mechanism driven by the coordinated function of mucus and motile cilia. Although ciliary beat frequency (CBF) reflects the motile function of ciliated cells, the generation and maintenance of ciliated cells are also essential for sustained airway epithelial defense. Although short-term treatment with ginsenoside Rd (Rd) increases CBF, its long-term effects on the differentiation of human airway epithelial cells remain unclear. We investigated the effects of Rd on primary normal human bronchial epithelial cells cultured under air-liquid interface conditions. On day 10, Rd increased the percentage of acetylated α-tubulin (Ac-α-tubulin)-positive cells, whereas the percentage of MUC5AC-positive cells remained unchanged. Rd promoted the time-dependent increase in Ac-α-tubulin-positive cells, while LDH release or total cell number were not significantly altered. Long-term Rd treatment did not affect baseline CBF. Furthermore, perfusion with Rd increased CBF independent of differentiation conditions. These observations suggest that the increase in Ac-α-tubulin-positive cells by long-term Rd treatment and the increase in CBF by short-term Rd treatment may be functionally separable. The increase in the percentage of Ac-α-tubulin-positive cells was suppressed by ERβ inhibitors and CREB-dependent transcription inhibitors. Rd also increased the expression of FOXJ1 mRNA transcripts. These findings suggest that Rd may modulate the expression of ciliated cell markers, such as acetylated α-tubulin and FOXJ1, and ciliary motility in human airway epithelial cells.
Indexed as
Identifiers
42773388What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.